Australia's largest stock trading and investment forum Australia's #1 stock forum

NEU

3.50%

$14.05 neuren pharmaceuticals limited

hottod: Brilliant post! Many thanks.wasa

First 2484 Last

Share
Profile

Follow
Wasabibarako

13,014 Posts.

781

19/10/22

17:02

Post #: 64283160
Share

Originally posted by hottod: ↑

I personally would prefer ROW rights not to go to Acadia. I’d prefer a highly committed, raring to go pharma/s with appropriate regulatory experience and sales force in the relevant ROW markets.

For other pharmas, free access to the full regulatory data package for trofinetide in Rett has substantial value. They are unlikely to attribute any value to indications outside of Rett, nor do I think there would be interest from other pharmas in taking on development of trofinetide in Fragile X exclusively for ex-US markets. Not a big enough carrot and too fraught with potential complications.

For its part, Acadia is unlikely to want to pay what another pharma/s might be willing to pay for trofinetide in Rett as it already has and has paid for all of the data! Acadia is also unlikely to want to attribute any value to ROW in Fragile X. And with no regulatory experience and sales force in Europe or Asia, Acadia would likely sublicense its ROW rights which would just add further to delays.

Of course, if Neuren’s main goal is to position itself as an attractive takeover target for Acadia, licensing ROW rights to Acadia might make sense. My concern is that this could come at a cost, not only of a less lucrative ROW deal now but also a less lucrative outcome in the event of future acquisition.

That said, I appreciate that many others here don’t share my view.

Ultimately, we shareholders are going to have to trust Management to navigate the best path as I’m sure there will be may factors that come into play here to which we are not privy.

Expand

hottod: Brilliant post! Many thanks.

wasa

NEU Price at posting: $7.52 Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BUX

Buxton projects new graphite province discovery at WA Narryer play

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 9,671 more messages in this thread...

First 2484 Last

Add NEU (ASX) to my watchlist

(20min delay)
Last $14.05		Change -0.510(3.50%)		Mkt cap ! $1.795B

Open	High	Low	Value	Volume
$14.38	$14.42	$13.94	$6.419M	454.6K

Buyers (Bids)

No.	Vol.	Price($)
1	500	$13.99

Sellers (Offers)

Price($)	Vol.	No.
$14.07	6644	4

View Market Depth

No.	Vol.	Price($)
1	500	13.990
1	300	13.970
1	1432	13.950
2	1230	13.900
1	720	13.890

Price($)	Vol.	No.
14.420	175	1
14.500	2985	2
14.800	2850	2
14.860	500	1
14.960	445	1

Last trade - 16.10pm 04/10/2024 (20 minute delay)

NEU (ASX) Chart

hottod: Brilliant post! Many thanks.wasa

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

hottod: Brilliant post! Many thanks.wasa

Top Stories

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News